Short answer
As of October 2026, GLP-1 ads that pass Meta review share one structural property: nothing in them asserts anything about the person seeing them. MedScale Health, a paid ads agency for US telehealth brands and clinics, builds GLP-1 creative around the program, the clinician and the mechanism rather than the patient, and the eight concept ads on this page show it for a fictional brand. Program-first creative stays clear of Meta's personal attributes rule and of the claims Meta still bans: inferiority statements, pinched-fat close-ups and timed promises without a qualifier.
What do GLP-1 ads that pass Meta review have in common?
Across GLP-1 advertising, the creative that clears review reliably has a single thing in common: no element of it makes a claim about the individual viewing it. MedScale works with telehealth brands and clinics, and applying that test at the brief stage removes most disapprovals before any creative is produced.
The no-claims-about-the-viewer test is stricter than checking against a list of banned words, and considerably more useful, because it catches new phrasings that no checklist anticipated. The eight concept ads at the end of this page apply it to a full set, and the fails-vs-passes list shows the line each one replaced.
What can a GLP-1 ad talk about without breaking Meta's rules?
Four subject areas keep GLP-1 ads clear of Meta's personal attributes rule, and they stay clear because they describe the offer rather than the audience.
- The clinician. Who prescribes, what their oversight involves, and how the clinical relationship works. This builds the credibility that converts in regulated care.
- The mechanism. How the program functions, what the process is, and what happens at each step.
- The logistics. Delivery, refills, adherence support, and access to clinicians. Practical and specific, which reads as trustworthy.
- Eligibility. Who the program is designed for, stated as a description of the service rather than as an assertion about the viewer.
How do you rewrite GLP-1 ad copy to pass Meta review?
The reliable move is grammatical. Where a non-compliant line makes the reader the subject, a compliant line makes the program the subject and carries the same information. MedScale writes every GLP-1 line with the program, not the viewer, as the subject.
"Struggling to lose weight?" attributes a condition to the reader. "A clinician-led weight management programme, prescribed online" describes the service. The proposition is identical; only one of them implies knowledge of the person reading it.
Which GLP-1 ad formats carry the least policy risk?
Format choice affects exposure independently of copy. Static creative featuring packaging, app interface or clinician imagery is the lowest-risk surface. Video works well when it follows the process rather than a person's body. Testimonials work best when they describe the experience of the program.
Meta's Health and Wellness policy lets weight-loss ads targeted to adults show people using the product or service, its impact, and the time taken to see results, and since July 22, 2026 a transformation is no longer banned on sight. MedScale still builds on the process rather than the body, because the claims around a transformation are where disapprovals start, and its own house rule is no before-and-after in the ads it runs. That is MedScale's choice, not Meta's rule.
Carousels deserve particular care, because sequential images can add up to a timed outcome promise across frames even where no single frame would fail on its own.
How do you stop GLP-1 ad disapprovals from recurring?
The teams that stay out of trouble treat compliance as a property of the brief rather than a review step at the end. When the default voice is set at the brief, every subsequent concept inherits it, and the disapproval rate falls structurally rather than through vigilance.
The teams that struggle produce creative conventionally and then attempt to sanitize it, which preserves the structure that caused the problem and reproduces it in the next batch. MedScale sets the default voice at the brief for that reason. A brand can have its current GLP-1 creative read against that test, ad by ad, in a free written audit from MedScale.
Does compliant GLP-1 creative perform worse?
A first compliant concept tested against creative refined over many iterations will lose, and the conclusion usually drawn from that is wrong. Compliant creative needs its own iteration budget before its performance ceiling is known.
MedScale treats it as a distinct testing surface for that reason. Measured against a properly developed baseline, the gap is much smaller than the first read suggests, and the account is not accruing enforcement risk while the learning happens.
What do failing and passing GLP-1 ad lines look like?
Ten rewrites, eight of them taken from the concept ads on this page. Each failing line breaks a Meta rule, an FDA warning or one of MedScale's house rules; each passing line carries the same offer without a claim about the viewer.
- Fails: "Tired of your weight? One price at every dose." Passes: "One price at every dose," with everything the price includes listed. The first asks about the viewer's body, which breaks the personal attributes rule.
- Fails: "Lose 20 lbs" next to a monthly price. Passes: the whole bill, line by line, from a brand that holds LegitScript certification and Meta authorization. The first promises a result; the second answers the price question without one, and Meta lists drug prices as allowed for authorized prescription drug advertisers.
- Fails: "Get Ozempic online in 24 hours." Passes: "4 steps, 0 waiting rooms," ending with "if your clinician prescribes it." The first names a branded drug the brand may not supply and promises speed; the second promotes the telehealth service.
- Fails: "Why pay double what you'd pay us?" Passes: "5 questions to ask any program," with no competitor named. The first is a comparative claim a reviewer would ask you to prove.
- Fails: "The same medication as Wegovy, for less." Passes: "Compounded, explained": compounded drugs are not FDA-approved and are not generic versions of brand-name drugs. FDA's June 15, 2026 page warns telehealth companies against exactly that sameness claim.
- Fails: a stock photo of a "doctor" with a quote. Passes: "A real clinician, on your schedule," showing the video visit as the product screen. MedScale never presents an actor or an AI-generated person as a clinician.
- Fails: "Down two sizes by summer." Passes: "The dose goes up, the price doesn't," a price chart labelled illustrative, with dosing left to the clinician. Meta bans promised results within a set time without a disclaimer or qualifier.
- Fails: "Still struggling with cravings?" Passes: "Text your care team," shown as a text exchange about delivery and dosing questions. The first is a second-person question about the viewer's health.
- Fails: a close-up of a hand pinching stomach fat. Passes: packaging, the intake screen or the consult. Meta's Health and Wellness policy bans pinched-fat close-ups in weight loss ads.
- Fails: "Hate what you see in the mirror?" Passes: "A clinician-led weight program, prescribed online when it fits." The first is a statement of inferiority about appearance as well as a personal attributes violation.
What do the eight GLP-1 concept ads on this page show?
The eight concept ads on this page were made by MedScale for Lumen Lane Health, a brand that does not exist, so no client's work is shown. Each caption says what the ad shows, the rule it clears and the line that would have failed review in its place. Together they cover the price, how the service works, the compounded disclosure, the clinician, dosing and support: the questions a GLP-1 buyer asks, answered without a single sentence about the viewer's body.
The concept ads show structure, not copy to reuse word for word. A real brand's ads need its own offer and its own clinicians, and anything that promotes the drug itself needs LegitScript certification and Meta authorization first.
Concept ads for a fictional brand
8 GLP-1 ads built to pass review
Made for this page, for a brand that doesn't exist, so no client's work is shown. Each one is built to pass review, and every caption names the rule it clears.
Common questions
- 01Can I show a person in a GLP-1 ad at all?
- Yes. Meta lets weight-loss ads targeted to adults show people using the product or service and its impact. What still fails is a close-up pinching fat, a statement of inferiority about someone's appearance, and a promised result in a set time without a qualifier. Clinicians, staff and patients in ordinary contexts raise none of these.
- 02Are testimonials allowed in weight loss advertising?
- Yes. A testimonial about convenience or clinician access is the safest. One that reports weight lost has to reflect what customers can generally expect under FTC guidance, which says a results-not-typical line does not cure a dramatic claim, and on Meta it cannot promise a result in a set time without a qualifier.
- 03How many creative concepts should a GLP-1 account be testing?
- Several at once: enough that no single disapproval stalls delivery, which in practice means maintaining several distinct compliant concepts rather than iterating on one. Concentration in a single concept family is a delivery risk as much as a performance one.
- 04Does compliant creative always perform worse?
- No, not once it has been developed properly. The comparison that produces that conclusion is usually between refined non-compliant creative and a first compliant attempt, which is not a fair test. Given equivalent iteration, the difference narrows considerably.
Sources
- 01Meta Advertising Standards: Health and Wellness (updated Jul 22, 2026)checked October 11, 2026
- 02Meta Advertising Standards: Privacy Violations and Personal Attributeschecked October 7, 2026
- 03Meta Advertising Standards: Introductionchecked October 7, 2026
- 04Meta Advertising Standards: Drugs and Pharmaceuticalschecked October 7, 2026
- 05Meta Business Help Center: About Meta's Prescription Drugs advertising policychecked October 7, 2026
- 06FDA (Jun 15, 2026): FDA to telehealth companies, what to know when promoting compounded drugschecked October 7, 2026
- 07FTC: Health products compliance guidancechecked October 5, 2026
- 08FTC: Endorsement Guides, what people are askingchecked October 5, 2026
Related answers
What Is Meta's Personal Attributes Policy and Why Does It Block Weight Loss Ads?
As of October 2026, Meta's Privacy Violations and Personal Attributes policy says “ads must not contain content that asserts or implies personal attributes,” and it names “physical or mental health (including medical conditions),” so weight loss copy about the reader's body fails. MedScale Health, a paid ads agency for US telehealth brands and clinics, checks every weight loss ad against that sentence before it spends and writes the creative in brand voice, so no line is about the viewer. Meta's change log shows the policy unchanged since June 2024.
Reviewed October 24, 2026
Can You Use Before and After Photos in GLP-1 Ads?
As of October 2026, GLP-1 and weight loss ads on Meta targeted to adults 18 and over can use before-and-after photos, because Meta's July 22, 2026 Health and Wellness update stopped rejecting them on sight; the claims around the image now decide review. MedScale Health, a paid ads agency for US telehealth brands and clinics, treats the format as usable but unforgiving and uses no before-and-after imagery in the ads it builds. Inferiority statements, pinched-fat close-ups and timed outcome promises without a disclaimer still fail.
Reviewed October 24, 2026
Can You Advertise GLP-1 on Facebook and Instagram?
As of November 2026, GLP-1 telehealth brands can advertise on Facebook and Instagram to adults 18 and over if no copy implies the viewer's body or health; a prescription GLP-1 also needs LegitScript certification and Meta's authorization. MedScale, a paid ads agency for US telehealth brands and clinics, builds GLP-1 creative against those rules from the first concept, because accounts are lost to a pattern of disapprovals, not one banned claim. Since July 22, 2026, Meta judges before-and-after imagery by the claims around it.
Reviewed November 9, 2026
What Should You Do When Meta Restricts Your Telehealth Ad Account?
As of October 2026, a telehealth brand whose Meta ad account is restricted should not open a replacement account, Page or Business Manager; it should find the policy Meta cited, fix it, and request one review. MedScale Health, a paid ads agency for US telehealth brands and clinics, follows that order: establish what was cited, remove the live violations, verify the business, then file one review with the problem already corrected, while budget moves to the other platform still open.
Reviewed November 3, 2026
Last reviewed October 24, 2026. Platform policies change often; we re-verify every answer quarterly.